Food as an inducer or reducer of metabolic syndrome pathways: a modern view on food selection and dietary principles
Authors:
Ladislav Kužela
Authors‘ workplace:
Gastroenterologická ambulancia, Bratislava
Published in:
Forum Diab 2026; 15(1): 16-19
Category:
Topic
Overview
Metabolic syndrome (MetS) represents a cluster of interrelated metabolic abnormalities associated with a markedly increased risk of type 2 diabetes and cardiovascular disease. Its pathogenesis involves insulin resistance, chronic low-grade inflammation, visceral adipose tissue dysfunction, endothelial dysfunction, dyslipidemia and gut dysbiosis. Diet can act either as an “inducer” or a “reducer” of these pathogenic pathways. Recent evidence shifts the focus from individual nutrients to overall dietary patterns and the degree of food processing. High consumption of ultra-processed foods and sugar-sweetened beverages is consistently associated with increased MetS risk, whereas dietary patterns rich in minimally processed plant foods, dietary fibre, polyphenols and unsaturated fats exert protective metabolic effects. This review summarizes current evidence and translates it into clinically applicable dietary principles.
Keywords:
metabolic syndrome – insulin resistance – gut microbiome – dietary fibre – plant-based diet – polyphenols – ultra-processed foods
Sources
- Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep 2018; 20(2): 12. Dostupné z DOI: <http://dx.doi.org/10.1007/s11906–018–0812-z>.
- Swarup S, Zeltser R, Ahmed I et al. Metabolic Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
- Monteiro CA, Cannon G, Levy RB et al. Ultra-processed foods: what they are and how to identify them. Public Health Nutr 2019; 22(5): 936–941. Dostupné z DOI: <http://dx.doi.org/10.1017/S1368980018003762>.
- Lv J-L, Wei Y-F, Sun Y et al. Ultra-processed food consumption and metabolic disease risk: an umbrella review of systematic reviews with meta-analyses of observational studies. Front Nutr 2024;11 : 1306310. Dostupné z DOI: <http://dx.doi.org/10.3389/fnut.2024.1306310>.
- Muñoz-Cabrejas A, Guallar-Castillón P, Laclaustra M et al. Association between Sugar-Sweetened Beverage Consumption and the Risk of the Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients 2023; 15(2): 430. Dostupné z DOI: <http://dx.doi.org/10.3390/nu15020430>.
- Singh S, Olayinka OT, Jaslin Fr et al. Food Additives’ Impact on Gut Microbiota and Metabolic Syndrome: A Systematic Review. Cureus 2024; 16(8): e66822. Dostupné z DOI: <http://dx.doi.org/10.7759/cureus.66822>.
- Castro-Barquero S, Ruiz-León AM, Sierra-Pérez M et al. Dietary Strategies for Metabolic Syndrome: A Comprehensive Review. Nutrients 2020; 12(10): 2983. Dostupné z DOI: <http://dx.doi.org/10.3390/nu12102983>.
- Banaszak M, Górna I, Przysławski J. Non-Pharmacological Treatments for Insulin Resistance: Effective Intervention of Plant-Based Diets – A Critical Review. Nutrients 2022; 14(7): 1400. Dostupné z DOI: <http://dx.doi.org/10.3390/nu14071400>.
- Guo H, Ding J, Liang J et al. Associations of Whole Grain and Refined Grain Consumption With Metabolic Syndrome: A Meta-Analysis of Observational Studies. Front Nutr 2021; 8 : 695620. Dostupné z DOI: <http://dx.doi.org/10.3389/fnut.2021.695620>.
- McDonald D, Hyde E, Debelius JW et al. American Gut: an Open Platform for Citizen Science Microbiome Research. MSystems 2018; 383: e00031–18. Dostupné z DOI: <http://dx.doi.org/10.1128/mSystems.00031–18>.
- Rashidbeygi E, Mehrzad Samarin M, Sheikhhossein F et al. The Effect of Kefir Consumption on Blood Pressure and C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Endocrinol Diabetes Metab 2025; 8(6): e70124. Dostupné z DOI: <http://dx.doi.org/10.1002/edm2.70124>.
- Chen W, Liu X, Bao L et al. Health effects of the time-restricted eating in adults with obesity: A systematic review and meta-analysis. Front Nutr 2023; 10 : 1079250. Dostupné z DOI: <http://dx.doi.org/10.3389/fnut.2023.1079250>.
- [Diabetes and Nutrition Study Group (DNSG) of the EASD]. Evidence-based European recommendations for the dietary management of diabetes. Diabetologia 2023; 66(6): 965–985. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–023–05894–8>.
- [American Diabetes Association Professional Practice Committee]. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care 2024; 47(Suppl 1): S20-S42. Dostupné z DOI: <http://dx.doi.org/10.2337/dc24-S002>.
- [European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)]. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts 2024; 17(4): 374–444. Dostupné z DOI: <http://dx.doi.org/10.1159/000539371>. Erratum in: Obes Facts 2024; 17(6): 658. Dostupné z DOI: <http://dx.doi.org/10.1159/000541386>.
- Wiśniewska K, Okręglicka KM, Nitsch-Osuch A et al. Plant-Based Diets and Metabolic Syndrome Components: The Questions That Still Need to Be Answered – A Narrative Review. Nutrients 2024; 16(1): 165. Dostupné z DOI: <http://dx.doi.org/10.3390/nu16010165>.
- Valenzuela-Fuenzalida JJ, Bravo VS, Moyano Valarezo L et al. Effectiveness of DASH Diet versus Other Diet Modalities in Metabolic-Syndrome-Related Disorders: Systematic Review and Meta-Analysis. Nutrients 2024; 16(18): 3054. Dostupné z DOI: <http://dx.doi.org/10.3390/nu16183054>.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Forum Diabetologicum
2026 Issue 1
-
All articles in this issue
- Moderná diabetológia sa mení na medicínu komplexných biologických súvislostí
- Pathogenic paths of organ damage in metabolic syndrome
- Food as an inducer or reducer of metabolic syndrome pathways: a modern view on food selection and dietary principles
- Physical activity and reducing sedentary behavior as an important part of managing overweight and obesity
- The power of starvation: metabolic, hormonal, and psychological effects of intermittent fasting
- Microbiome – „compendium“ for diabetologists
- Obesity management through the lens of functional movement
- The effect of initiating and subsequently intermittent use of CGM/FGM technology on glycaemic control in patients with type 1 diabetes: a retrospective study from 4 centres
- The REALITA Project: a retrospective analysis of type 2 diabetes mellitus treatment in light of current standards
- Clinical guidelines for the prevention of cholelithiasis in high-risk patients treated with GLP-1 receptor agonists
- The pleiotropic effects of SGLT2 inhibitors and their mechanism
- Cardiovascular outcome trials – How to interpret their results, what to focus on, and their relevance for clinical practice
- Forum Diabetologicum
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Pathogenic paths of organ damage in metabolic syndrome
- The power of starvation: metabolic, hormonal, and psychological effects of intermittent fasting
- Microbiome – „compendium“ for diabetologists
- The pleiotropic effects of SGLT2 inhibitors and their mechanism